Pfizer has a long history of innovation in healthcare and research, across the world and in Australia.
In 1956 Pfizer commenced operations in Australia with just six people: an accountant, a medical director, two employees responsible for handling sample storage and two secretaries. Many of the diseases that significantly impacted the lives of Australians in the 60s and 70s can now be managed through medication because of the hard work and commitment of these first Pfizer employees, and the many colleagues who have since followed in their footsteps.
Today, Pfizer Australia employs 1,700 colleagues in a variety of fields including science, medical, regulatory affairs, manufacturing, sales and marketing, health economics, research and development. Every day our people work together with the sole purpose of ensuring that Australians can access new and innovative medicines that are being used to treat some of the most feared conditions of our time.
Pfizer in Australia
Incorporation of Pfizer Australia
Opening of West Ryde head office and manufacturing facility
Launch of sustained-release drug ‘Eryc’ (enteric-coated pellets of erythromycin)
Acquisition of G-Chem
Discover and launch of the world’s first patient-controlled analgesia (PCA) device
Acquisition of David Bull Laboratories
Establishment of joint venture with CSIRO to develop new drugs under Keating government’s “Factor f” scheme
Triple rollout of major new medicines: Zoloft®, Norvasc® and Zithromax®
Launch of Lipitor®
Acquisition of Pharmacia (including the manufacturing facility in Perth)
Acquisition of CSL Animal Health
Sale of Pfizer Consumer Health
Acquisition of Wyeth
Sale of Pfizer Nutrition
Spin off of Pfizer’s Animal Health unit, Zoetis
Acquisition of Baxter’s vaccines portfolio
Acquisition of Hospira
Pfizer celebrates 60 years in Australia
2016 is a wonderful opportunity to acknowledge and celebrate the contribution we have made to improving the health of Australians. We have an extensive medicines portfolio, a promising pipeline and an ongoing commitment to innovation that includes significant investment in local research and development.